ALTREN- altrenogest solution

Страна: Соединенные Штаты

Язык: английский

Источник: NLM (National Library of Medicine)

Активный ингредиент:

ALTRENOGEST (UNII: 2U0X0JA2NB) (ALTRENOGEST - UNII:2U0X0JA2NB)

Доступна с:

Aurora Pharmaceutical, Inc.

Администрация маршрут:

ORAL

Тип рецепта:

PRESCRIPTION

Терапевтические показания :

Horses: Altren® Solution 0.22% is indicated for suppression of estrus. Suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal. This facilitates the attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season. Suppression of estrus will also facilitate management of prolonged estrus conditions. Suppression of estrus may be used to facilitate scheduled breeding during the physiological breeding season. Swine: Altren® Solution 0.22% is indicated for suppression of estrus in sexually mature gilts. Altren® Solution 0.22% mimics the action of progesterone and blocks the cyclical release of gonadotrophins and thus the development of estrus. Following cessation of treatment, pituitary inhibition ceases and normal development and maturation of the follicles returns, leading to a return to estrus and ovulation. The predictable return to estrus (generally 5-7 days following cessation of treatment) allows for estrus synchroniza

Статус Авторизация:

Export only

Характеристики продукта

ALTREN- ALTRENOGEST SOLUTION
AURORA PHARMACEUTICAL, INC.
----------
ALTREN
SOLUTION 0.22%
(ALTRENOGEST)
2.2 mg/mL
ORAL PROGESTIN
FOR VETERINARY USE ONLY
DESCRIPTION:
Altren® (altrenogest) Solution 0.22% contains the active synthetic
progestin,
altrenogest. The chemical name is
17α-allyl-17β-hydroxyestra-4,9,11-trien-3-one. The
CAS Registry Number is 850-52-2. The chemical structure is:
Each mL of Altren® (altrenogest) Solution 0.22% contains 2.2 mg of
altrenogest in an oil
solution.
THERAPEUTIC CLASSIFICATION:
Altren® Solution 0.22% produces a progestational effect in mares and
gilts.
INDICATIONS:
HORSES: Altren® Solution 0.22% is indicated for suppression of
estrus. Suppression of
estrus allows for a predictable occurrence of estrus following drug
withdrawal. This
facilitates the attainment of regular cyclicity during the transition
from winter anestrus to
the physiological breeding season. Suppression of estrus will also
facilitate management
of prolonged estrus conditions. Suppression of estrus may be used to
facilitate
scheduled breeding during the physiological breeding season.
SWINE: Altren® Solution 0.22% is indicated for suppression of estrus
in sexually mature
gilts.
Altren® Solution 0.22% mimics the action of progesterone and blocks
the cyclical
release of gonadotrophins and thus the development of estrus.
Following cessation of
treatment, pituitary inhibition ceases and normal development and
maturation of the
follicles returns, leading to a return to estrus and ovulation. The
predictable return to
estrus (generally 5-7 days following cessation of treatment) allows
for estrus
®
synchronization in a pool of cycling gilts.
Altren® Solution 0.22% is indicated for suppression of estrus in
sexually mature gilts to:
1. Permit synchronization of estrus in cycling gilts.
2. Improve breeding unit organization by facilitating batch management
(all in, all out
system) of the breeding gilts.
3. Reduce the pre-breeding gilt pool size.
DOSAGE AND ADMINISTRATION:
HORSES: Administer orally at the rate